Johnson & Johnson

If stocks fall on back-to-back days for the first time this month, you can probably blame an old culprit: Covid. Yesterday was the biggest down day in a month, and it looks like the pullback is seeing a little follow-through, with stocks under pressure in pre-market trading despite solid earnings...

This weekend's Barron's cover story discusses why an American entertainment colossus has a bright future. Other featured articles show how proxy season is shaping up, and what the ramifications of the halt on one of the COVID-19 vaccines could be. Also, see the prospects for a pet wellness...

After a dull Monday, investors awake this morning to a couple of big news items. That being said, both the consumer price index (CPI) and a pause in the use of Johnson & Johnson’s (NYSE: JNJ) Covid vaccine seem to be having a muted impact on the market.  We’ll get to...

Benzinga has examined the prospects for many investor favorite stocks over the past week. The past week's bullish calls included the iPhone maker, Google's parent and an automotive leader. Financial and energy giants and COVID-19 vaccine makers were among the bearish calls seen during the...

This weekend's Barron's cover story explores how investors can benefit from the shift to green energy. Other featured articles discuss value stocks to ride the economic recovery, what the spike in bond yields means for stocks, and tech stocks resisting the sector downturn. Also, the...

On January 27, the Horizons Psychedelic Stock Index ETF (NEO:PSYK) became the first exchange traded fund to focus solely on the psychedelics industry.  Horizons ETFs CEO Steve Hawkins sat down with Benzinga to discuss the listing, which brought in approximately CA$25 million ($19.4 million) in...

This weekend's Barron's cover story explains why the online renegades that took the investing world by storm are just getting started. Other featured articles offer Barron's Roundtable stock picks for 2021, examine how retail has changed over the past century and ponder what's...

The last day of a volatile and heavily traded stock market week opens this morning with investors apparently feeling uneasy given the state of certain speculative trades that have been in the spotlight for days. At the moment it seems like there is a little bit of turnover in the market, with...

Trying to keep up with all the earnings news? It’s a challenge, but a welcome one for many investors anxious to see how Q4 turned out for the major companies.  The day begins with a fresh batch of earnings data but nothing new on the vaccine front. Johnson & Johnson (NYSE:...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. According to recent information published on WHO's 2019 Global Health Estimates, heart disease remains the leading cause of death...

The pandemic devastated the global economy, forcing businesses and content providers to rethink their marketing and communications strategies. In unpacking how the biggest personalities and organizations like Lionsgate, DreamWorks, AMC Entertainment Holdings Inc (NYSE: AMC), Facebook Inc (NASDAQ:...

This weekend's Barron's offers the guidance of a variety of experts on what's ahead for the global economy and the markets. Another featured article examines why the Dividend Aristocrats may be the best bet now. Also, the prospects for bank stocks and a highly anticipated IPO...

The Past Week, In A Nutshell What Happened: Last week ended negative despite better-than-expected earnings. Remember This: “Overall market performance also tends to stall leading into an election," said Phil Mackintosh, Nasdaq Chief Economist. "Although once a result is known,...

Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of October 19th – 25th, 2020. Without further ado, let’s get started. * Yahoo Finance readers, please click...